These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 28893303)

  • 1. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    Tang S; Xiang C; Yang Q
    Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI.
    Savaridas SL; Vinnicombe SJ; Warwick V; Evans A
    Br J Radiol; 2023 Aug; 96(1148):20220921. PubMed ID: 37399083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography in patients with MRI contraindications.
    Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
    Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer.
    Steinhof-Radwańska K; Grażyńska A; Lorek A; Gisterek I; Barczyk-Gutowska A; Bobola A; Okas K; Lelek Z; Morawska I; Potoczny J; Niemiec P; Szyluk K
    Curr Oncol; 2021 Sep; 28(5):3448-3462. PubMed ID: 34590596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
    Savaridas SL; Taylor DB; Gunawardana D; Phillips M
    Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
    Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
    Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
    Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
    Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
    An YY; Kim SH; Kang BJ
    World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
    Goorts B; Dreuning KMA; Houwers JB; Kooreman LFS; Boerma EG; Mann RM; Lobbes MBI; Smidt ML
    Breast Cancer Res; 2018 Apr; 20(1):34. PubMed ID: 29669584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
    Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
    Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can unenhanced MRI of the breast replace contrast-enhanced MRI in assessing response to neoadjuvant chemotherapy?
    Cavallo Marincola B; Telesca M; Zaccagna F; Riemer F; Anzidei M; Catalano C; Pediconi F
    Acta Radiol; 2019 Jan; 60(1):35-44. PubMed ID: 29742918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.